![Chad Decker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Chad Decker first degree
Entity | Entity type | Industry | |
---|---|---|---|
Alphazyme LLC
![]() Alphazyme LLC Miscellaneous Commercial ServicesCommercial Services Part of Maravai Lifesciences Holdings, Inc., Alphazyme LLC is a company that specializes in the development and production of custom molecular biology enzymes at an industrial scale. The company is based in Jupiter, FL. The company collaborates with manufacturers of nucleic acid synthesis and detection platforms to produce high-quality and affordable enzymes for the growing markets of custom DNA and RNA molecules, genomic medicines, and genetic analysis. Alphazyme's mission is to be the world's premier partner for industrial-scale molecular biology enzymes. The company was founded by Christopher Benoit, who has been the CEO since incorporation. Alphazyme was acquired by Maravai Lifesciences Holdings, Inc. on February 22, 2023, for $145 million.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Chad Decker via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
QIAGEN Beverly LLC
![]() QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Biotechnology | Founder | |
University of Massachusetts | College/University | Undergraduate Degree | |
New England Biolabs, Inc.
![]() New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | Chemicals: Specialty | Corporate Officer/Principal | |
Twinstrand Biosciences, Inc.
![]() Twinstrand Biosciences, Inc. Medical SpecialtiesHealth Technology Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA. | Medical Specialties | Chief Executive Officer |
Statistics
International
United States | 5 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Process Industries | 2 |
Operational
Director/Board Member | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Undergraduate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Christopher Benoit | 5 |
- Stock Market
- Insiders
- Chad Decker
- Company connections